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Introduction 
Antimicrobial Drugs (AMDs) are widely used in modern medicine practice to 
prevent potential infections (prophylactic therapy) or manage existing infectious 
diseases. Microorganisms such as bacteria, fungi, viruses, and parasites mutate all 
the time naturally.  However, exposure to antimicrobial drugs causes selection of 
resistant strains, rendering AMD less effective or ineffective. The emergence and 
spread of AMD resistance present a significant global public health threat. The 
2016 O’Neill review estimated about 700,000 die every year from drug-resistant 
strains of common bacterial infections.  However, if the current situation is left 
unchecked, this could rise to 10 million deaths annually by the year 2050 and 
associated cumulative cost to the global economy of over 100 trillion.[1] The 
middle and lower-income countries are disproportionally affected: eighty-nine 
percent of the 10 million fatalities would be in Africa and Asia.[2]
Antimicrobial Drug Resistance (AMDR) often occurs as a result of the 
inappropriate use of antimicrobial drugs, including over- and under-prescribing. 
It is estimated that 8% of hospitalized COVID-19 patients experienced bacterial 
infections while 72% received antibiotics.[3] Overuse of specific antibiotics 
increases the likelihood of resistance.
The World Health Organization (WHO) has reported on several instances of 
AMDR, such as multidrug resistant TB (MDR-TB), which has been reported 
in all regions of the world, and extensively drug-resistant TB (XDR-TB), which 
is resistant to at least four of the core TB drugs. Moreover, resistance has also 
emerged to carbapenem antibiotics, the last resort for treatment of Klebsiella 
pneumonia, a common intestinal bacterium that can cause life-threatening 
infections, and a significant cause of hospital-acquired infections. However, 
developing a new drug costs a significant amount of time and money. Therefore, 
promoting good antimicrobial prescribing practice is a feasible way to combat 
the growing AMR threat.
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Abstract
Antimicrobial drugs are the basis of modern medicine, saving lives and 
allowing surgery and chemotherapy to be possible. Inappropriate use of 
antimicrobials has led to resistance, meaning we can no longer rely on them 
being effective. This is further complicated by a lack of new drugs coming 
to market. Antimicrobial resistance is a well-documented global problem 
and threatens low and middle-income countries (LMIC) disproportionately. 
A “One Health” approach is needed, tackling antimicrobial use inhuman, 
veterinary, agriculture and environmental sectors. Many health professionals 
are aware of antimicrobial resistance but struggle to know how to change their 
practice safely. Here, the author reports on her experience as an antimicrobial 
pharmacist at Betsi Cadwaladr University Health Board (BCUHB) in Wales 
and observing practices in Eswatini. BCUHB used various strategies and tools 
to support prescribers to change prescribing practice. Some of these tools were 
specifically aimed at primary care prescribers. Similar tools could be developed 
to support prescribers in LMIC. Antimicrobial resistance cannot be ignored 
and action is needed now.
Keywords: Antimicrobial Stewardship (AMS), Antimicrobial Resistance 
(AMR), antibiotics, low and middle-income countries (LMIC), primary care
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Several efforts aimed to slow down the emergence and 
spread of AMR strains have been introduced, including 
World Antimicrobial Awareness Week which occurs 
annually each November. Its main objectives are to 
increase awareness of global antimicrobial resistance and 
to encourage best practices among the general public, 
health workers and policy makers to avoid the further 
emergence and spread of drug-resistant infections.
Fighting AMR requires a “One health” approach that 
covers human, veterinary, agricultural, and environmental 
sectors.[2] However, this article will focus mainly on 
the antimicrobial stewardship approach in fighting 
antimicrobial resistance adopted at the Betsi Cadwaladr 
University Health Board (BCUHB), with whom the 
author worked.
Antimicrobial Stewardship Approach 
Antimicrobial Stewardship is an organizational or 
healthcare system broad approach that promotes and 
monitors antimicrobial usage in the health care sector. 
However, Antimicrobial Stewardship cannot successfully 
fight AMR without infection control and vaccination 
programs. As part of the global effort to combat AMR, 
the WHO in 2015 introduced five strategic objectives: 
• to improve awareness and understanding of 
antimicrobial resistance;
• to strengthen knowledge through surveillance and 
research;
• to reduce the incidence of infection;
• to optimize the use of antimicrobial agents
• to develop the economic case for sustainable 
investment that takes account of the needs of 
all countries, and increase investment in new 
medicines, diagnostic tools, vaccines and other 
interventions.
Between 2017-2019, BCUHB achieved a 12.6% 
reduction in the volume of antimicrobial drugs prescribed 
in primary care.[4] The interventions used can be grouped 
in the following categories: educational programme, 
multidisciplinary approach, adherence to antimicrobial 
prescription guidelines, and surveillance.  
Educational program 
One of the most useful tools in our approach was 
educating health care professionals, especially those under 
training. This ensured that they understood the threat 
of antimicrobial resistance and the impact of irrational 
prescribing of antimicrobials on patients and public health 
in general. The following resources can be helpful.
FutureLearn[5] runs various free access courses on 
Antimicrobial Resistance and Stewardship for health 
professionals, including:
• Antimicrobial Stewardship for Africa;
• Antimicrobial Stewardship: Managing Antibiotic 
Resistance;
• The role of Antifungal Stewardship;
• TARGET Antibiotics-Prescribing in Primary 
Care; 
• Utilizing Social Science and Behaviour Change 
in Antimicrobial Stewardship Programmes: 
Improving Health Care;
• Challenges in antibiotics Point Prevalence surveys.
As well as discussing the importance of Antimicrobial 
Stewardship, they also discuss strategies that can be used 
to tackle antimicrobial resistance.
The WHO also runs the online course, “Antimicrobial 
Stewardship: A competency-based approach.”[6]
It is important to educate children about infection control 
and antibiotic use. E-bug [7] is a free educational resource 
for the classroom which provides lesson plans for teachers 
and teaches school children about microorganisms, 
how disease spreads, and basic information about 
antimicrobials. Resources are available for school students 
of different ages and in different languages. 
Promoting non-prescribing of antibiotics where 
appropriate
General Practitioners in BCUHB were aware of the 
problem of antimicrobial resistance but struggled to 
identify how they could change their prescribing habits 
safely.  The majority of antibiotic prescribing occurs 
outside the hospital, so it is important to support primary 
care prescribers, although historically, most resources have 
been directed at hospital prescribing.
The Royal College of General Practitioners in the UK 
developed the TARGET (Treat Antibiotics Responsibly, 
Guidance, Education Tools) toolkit[8] to help influence 
prescribers’ and patients’ personal attitudes and perceived 
barriers. To develop the tools, they asked the question 
“why do primary care staff prescribe antibiotics”. They 
identified three key reasons:
• Relief of symptoms;
• Worry about complications/more serious illness;
• Patient pressure.
They then developed training material and patient 
information leaflets that could be used instead of 
an antibiotic prescription. The leaflets were aimed 
at commonly presenting infections and tackled the 
questions above. The leaflets explained why an antibiotic 
was not necessary, for how long patients could expect to 
experience symptoms, how they could help themselves, 
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and when to get help if symptoms did not improve. Use of 
the TARGET toolkit is discussed in a FutureLearn online 
course.[5]
The TARGET toolkit leaflets were appreciated by 
prescribers in BCUHB and were a successful tool in 
driving change, giving prescribers the confidence to know 
when an antibiotic was not appropriate. Similar leaflets 
could be beneficial in LMIC, including South Sudan, 
giving prescribers the confidence to know when it is safe 
not to prescribe an antibiotic.
Team Approach
BCUHB recognised the importance of a team approach 
and developed the Safe Clean Care initiative. Safe Clean 
Care is a multidisciplinary behavioural change program 
that sets out clear achievable goals.
Importantly Safe Clean Care had management support.
The initiative acknowledged everybody’s involvement in 
preventing healthcare-acquired infection and prevention 
of antimicrobial resistance by including consultants to 
cleaners in the meetings. The approach adopted was to 
listen to staff, to understand barriers to change, to recognize 
good practice but also to implement consequences for 
staff who repeatedly failed to comply with initiatives such 
as “bare below the elbow”.
Instead of concentrating on what could not be changed, 
e.g. hospital buildings, areas that could be changed were 
targeted, e.g. de-cluttering the wards.
Safe Clean Care empowered staff to make a change and 
acknowledged their work. It allowed people to start to 
make a difference rather than being overwhelmed by 
the problem. As a result, staff morale and patient care 
improved.
Antimicrobial Prescribing Guidelines
Advice for prescribers on which antibiotics to prescribe is 
essential for prudent antimicrobial prescribing. BCUHB 
were fortunate to have a formulary developed and updated 
at local level based on sensitivities. This is not the case in 
many LMIC but there are other tools available that can 
help. The WHO in 2017 introduced the Access, Watch, 
Reserve (“AWaRe”) classification of antibiotics in its 
Essential Medicines List.[9] The classification is a tool for 
antibiotic stewardship at local, national and global levels 
with the aim of reducing antimicrobial resistance.
The Commonwealth Pharmacists Association, as part 
of their Commonwealth Partnership for Antimicrobial 
Stewardship, has supported Ghana, Tanzania, Uganda 
and Zambia to develop antimicrobial Formularies and 
publish them on the Micro Guide app along with other 
useful prescribing information.[10]
South Africa has also developed a pocket guide to antibiotic 
prescribing, which, as well as being a formulary, explains 
the principles behind antibiotic prescribing, the likely 
pathogen causing infection, the penetration of antibiotics 
at different sites and antibiotic sensitivities.[11]
Surveillance
One of the strategic objectives outlined in the WHO 
5-point strategy discussed above is to strengthen 
knowledge through surveillance and research. At the local 
level, accurate sensitivity data help to identify appropriate 
treatment, but when shared, it can be used on a national 
and global level. Many LMIC have limited lab resources, 
which makes both the individual patient decision difficult 
and the extent of resistance within the country unknown.
Resources that may be useful are:
• GLASS promotes and supports a standardized 
approach to the collection, analysis, and sharing of 
AMR data at a global level.[12]
• The Global Point Prevalence Survey of 
Antimicrobial Consumption and Resistance 
(Global-PPS) is a simple freely available web-based 
tool that measures and monitor antimicrobial 
prescribing in hospitals worldwide. The system 
also offers feedback and help in identifying hospital 
interventions and identifying targets.[13]
• The Centre for Disease Dynamics, Economics 
and Policy provides information on antibiotic use 
and antibiotic resistance at the country level where 
information is available.[14]
Conclusion
Antimicrobial Stewardship is complicated but possible. 
Although health professionals are often aware of the risk 
that overuse of antimicrobials will cause resistance, they 
often do not know how to safely reduce their prescribing of 
antibiotics and feel their actions will not make a difference. 
Clear prescribing guidelines and tools can support 
antimicrobial stewardship and encourage individuals and 
institutions to begin to tackle the problem. Antimicrobial 
resistance is not a problem that will go away and action 
is needed now in all countries including South Sudan. In 
many LMICs patients can obtain antimicrobials without 
prescription, so interventions directed at prescribers also 
need to include pharmacists and pharmacy assistants.
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COVID-19 UPDATES
South Sudan Corona Dashboard
Click https://corona-scanner.com/country/south-sudan for on-going updates on COVID-19 in South Sudan. Corona 
Scanner https://corona-scanner.com/  is a free online dashboard solution which offers real-time coronavirus statistics 
like the amount of infections, deaths, still sick and recovered people per country. More statistics are coming very 
soon. The data displayed on this website originate from reliable sources (global health institutes) and is automatically 
updated every 30 seconds. Please note that the data only includes verified cases, which means that the exact numbers 
can vary from the numbers provided by news / social media sources.
Seven things to know about COVID-19 variants in Africa
https://www.afro.who.int/news/seven-things-know-about-covid-19-variants-africa 
22 January 2021 Brazzaville. New COVID-19 variants have emerged in Africa as the continent records a new peak 
in infections. While virus mutations are not unusual, those that are more infectious are worrisome. On this site 
Professor Francisca Mutapi, Professor in Global Health Infection and Immunity, University of Edinburgh, answers 
the following questions.
1. Why do viruses mutate, and should we be worried about SARS-CoV-2 variants?
2. Mutation, variants, lineages and strains are used quite often. What is the difference?
3. How many variants are circulating in Africa and what do we know about them?
4. What is the implication of the variants on COVID-19 transmission, therapeutics and vaccines?
5. Does vaccine development take virus mutation into consideration?
6. Can vaccines be restructured to tackle virus mutations that emerge later?
7. What should Africa countries do to better respond to the new variants?
Gordon Memorial College Trust Fund applications for 2021/2022
The deadline for Gordon Memorial College Trust Fund(GMCTF)  grant applications for the academic year 2021/2022 is 28th 
February 2021. New applicants, and those wishing to  renew their grants after successful progress in their current courses, should 
go the website www.gmctf.org to submit their applications before the deadline.
Eluzai Hakim,  Associate Editor SSMJ
